Dopamine D2R/DRD2 Antibody - BSA Free

The DRD2 Dopamine Receptor is involved in the neuromodulation of appetitive behaviors. DRD2 may be linked to alcoholism and other substance-use disorders. Mutations in DRD2 in mice lead to the suppression of reward behavior with morphine and to the reduction of spontaneous movements, a phenotype resembling Parkinson's disease. Three alternatively spliced isoforms have been identified. DRD2 has been reported to be expressed in various regions of the brain, as well as in aorta, artery, eye, and spinal cord. ESTs have been isolated from normal pituitary and in brain, colon, lung, pancreas, and skeletal muscle cancer libraries.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: IHC-P.

Showing Publications 1 - 2 of 2.

Publications using NLS1403	Applications	Species
Kanakis G, Grimelius L, Spathis A et al. Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role. Neuroendocrinology. 2015-02-26 [PMID: 25765100]
Srirajaskanthan R, Watkins J, Marelli L et al. Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies. Neuroendocrinology 2009-01-01 [PMID: 19307732] (IHC-P, Human)	IHC-P	Human

Array NLS1403

• Dopamine D2R/DRD2 Antibodies
• Dopamine D2R/DRD2 ELISA Kits
• Dopamine D2R/DRD2 Lysate
• Dopamine D2R/DRD2 Proteins